Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
470.60    0.60 (0.13%)
Bid:
469.80
Ask:
470.20
Spread: 0.40 (0.085%)
Market Cap: £2.43b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Buyback Programme 3rd Tranche

3 Feb 2025 07:00

RNS Number : 5563V
QinetiQ Group plc
03 February 2025
 

News release

QinetiQ Group plc

Commencement of Third Tranche of Buyback Programme

3 February 2025 - QinetiQ Group plc ("QinetiQ" or the "Group") confirms the completion by Numis Securities Limited ("Deutsche Numis") of the second tranche of its £100 million share buyback programme (the "Programme") announced on 16 January 2024. As announced on 14 November 2024, QinetiQ is extending the Programme by £50m to deliver increased shareholder returns.

QinetiQ has today entered into an agreement with Deutsche Numis to extend the Programme through the execution of a third tranche ("the Third Tranche) with a maximum aggregate value of up to £50 million. Under the Third Tranche, which is expected to complete by no later than 30 June 2025, Deutsche Numis will make trading decisions independently of QinetiQ in accordance with certain pre-set parameters. The Third Tranche will be effected under the authority granted by shareholders at QinetiQ's Annual General Meeting held on 18 July 2024, and the maximum remaining number of shares that may be repurchased under the Third Tranche pursuant to that authority is 42,778,600 Ordinary Shares.

Any purchases under the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with the Buyback Authority, Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse (Amendment) (EU Exit) Regulations 2019.

Any Ordinary Shares purchased pursuant to the Programme will be cancelled, and the number of Ordinary Shares in issue reduced accordingly.

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

For further information please contact:

Stephen Lamacraft, Group Interim Director Investor Relations: +44 (0) 7471 885817

Lindsay Walls, Group Communications Director (Media enquiries): +44 (0) 7793 427582

James Field, Company Secretary: +44 (0) 7841 662957

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDGGDDCGGDGUB
Date   Source Headline
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report
25th May 20237:00 amRNSResults for the year ended 31 March 2023
10th May 20234:55 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSFourth Quarter Trading Update
12th Apr 202311:35 amRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSQinetiQ announces £259 million renewal of MSCA
30th Mar 20237:00 amRNSQinetiQ Awarded $92.6M Contract
23rd Mar 20235:00 pmRNSDirectorate Change
20th Mar 202310:30 amRNSDirector Declaration
15th Mar 20232:40 pmRNSDirector Declaration
10th Mar 20232:56 pmRNSDirector/PDMR Shareholding
17th Feb 20239:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSGary Stewart appointed CEO for Australia Sector
10th Feb 20231:14 pmRNSDirector/PDMR Shareholding
6th Feb 20231:44 pmRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSThird Quarter Trading Update
16th Jan 20237:00 amRNS£80m contract win with UK MOD
10th Jan 20233:43 pmRNSDirector/PDMR Shareholding
5th Jan 20232:38 pmRNSDirector Declaration
12th Dec 20225:23 pmRNSDirectorate Change
12th Dec 20221:44 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSCompletion of the acquisition of Air Affairs
23rd Nov 202212:16 pmRNSCompletion of the acquisition of Avantus
10th Nov 202212:13 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSSecond Quarter Trading Update
11th Oct 20223:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:06 amRNSAcquisition of Air Affairs & disposal of Space NV
12th Sep 20223:28 pmRNSDirector/PDMR Shareholding
26th Aug 202212:53 pmRNSDirector/PDMR Shareholding
10th Aug 20223:36 pmRNSDirector/PDMR Shareholding
9th Aug 20227:00 amRNSDelivering growth in the US with $45m contract win
5th Aug 20226:22 pmRNSProposed Acquisition of Avantus Federal LLC
1st Aug 20223:19 pmRNSHolding(s) in Company
21st Jul 20223:18 pmRNSResult of AGM
21st Jul 20227:00 amRNSFirst Quarter Trading Update
19th Jul 20225:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.